IP Library Granted Patent US 11,584,770
Granted Patent B2
US 11,584,770 · App. 16/886,985 · Granted Feb 21, 2023

Methods of preparing nicotinamide riboside and derivatives thereof

Inventors: Marie Migaud (Lurgan, GB); Philip Redpath (Portadown, GB); Kerri Crossey (Magherafelt, GB); Mark Doherty (Newtownabbey, GB)
Assignee: The Queen's University of Belfast
C07H19/048C07H1/00C07H1/06C07H19/04Y02P20/582
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,584,770
App. No.
16/886,985
Granted
Feb 21, 2023
Kind
B2
Abstract

Methods of preparing nicotinamide riboside and derivatives thereof. In an aspect, the invention relates to a method of preparing a compound of formula (I) wherein n is 0 or 1; m is 0 or 1; Y is O or S; R 1 is selected from H, substituted or unsubstituted alkyl, substituted or unsubstituted alkenyl, substituted or unsubstituted alkynyl, substituted or unsubstituted aryl, substituted or unsubstituted primary or secondary amino, and substituted or unsubstituted azido; R 2 -R 5, which may be the same or different, are each independently selected from H, substituted or unsubstituted alkyl, substituted or unsubstituted alkenyl, substituted or unsubstituted alkynyl, and substituted or unsubstituted aryl; and X − is an anion, selected from an anion of a substituted or unsubstituted carboxylic acid, a halide, a substituted or unsubstituted sulfonate, a substituted or unsubstituted phosphate, a substituted or unsubstituted sulfate, a substituted or unsubstituted carbonate, and a substituted or unsubstituted carbamate.

Claims (50)

1. A compound of formula (IV)

wherein

n is 0 or 1;

m is 0 or 1;

Y is S;

R 1 is selected from H, substituted or unsubstituted alkyl, substituted or unsubstituted alkenyl, substituted or unsubstituted alkynyl, substituted or unsubstituted aryl, substituted or unsubstituted primary or secondary amino, and unsubstituted azido;

R 2 -R 5 , which may be the same or different, are each independently selected from H, substituted or unsubstituted alkyl, substituted or unsubstituted alkenyl, substituted or unsubstituted alkynyl, and substituted or unsubstituted aryl; and

R 6 , R 7 and R 8 , which may be the same or different, are each independently a hydroxyl protecting group; and

X − is an anion selected from an anion of a substituted or unsubstituted carboxylic acid, a halide, a substituted or unsubstituted sulfonate, a substituted or unsubstituted phosphate, a substituted or unsubstituted sulfate, a substituted or unsubstituted carbonate, and a substituted or unsubstituted carbamate,

provided that when n is 0, m is 1, and R 2 -R 5 are each H, then R 1 is not NH 2 .

2. The compound of claim 1 , wherein R 2 -R 5 are each H.

3. The compound of claim 1 of formula (IVA)

wherein

n is 0 or 1;

m is 0 or 1;

Y is S;

R 1 is selected from H, substituted or unsubstituted alkyl, substituted or unsubstituted alkenyl, substituted or unsubstituted alkynyl, substituted or unsubstituted aryl, substituted or unsubstituted primary or secondary amino, and unsubstituted azido; and

R 2 -R 5 , which may be the same or different, are each independently selected from H, substituted or unsubstituted alkyl, substituted or unsubstituted alkenyl, substituted or unsubstituted alkynyl, and substituted or unsubstituted aryl; and

R 6 , R 7 and R 8 , which may be the same or different, are each independently a hydroxyl-protecting group X − is an anion, selected from an anion of a substituted or unsubstituted carboxylic acid, a halide, a substituted or unsubstituted sulfonate, a substituted or unsubstituted phosphate, a substituted or unsubstituted sulfate, a substituted or unsubstituted carbonate, and a substituted or unsubstituted carbamate,

provided that when n is 0, m is 1, and R 2 -R 5 are each H, then R 1 is not NH 2 .

4. A substantially isomerically pure compound of formula (III) having a beta-D-ribofuranosyl configuration:

wherein,

n is 0 or 1;

m is 0 or 1;

Y is O or S;

R 1 is selected from H, substituted or unsubstituted alkyl, substituted or unsubstituted alkenyl, substituted or unsubstituted alkynyl, substituted or unsubstituted aryl, substituted or unsubstituted primary or secondary amino, and substituted or unsubstituted azido; and

R 2 -R 5 , which may be the same or different, are each independently selected from H, substituted or unsubstituted alkyl, substituted or unsubstituted alkenyl, substituted or unsubstituted alkynyl, and substituted or unsubstituted aryl; and

R 6 , R 7 and R 8 , which may be the same or different, are each independently a hydroxyl-protecting group;

or

R 6 , R 7 and R 8 are each H; and

wherein the compound has greater than 90% chemical purity, and comprises at least 98% diastereomeric purity of the beta-D-ribofuranosyl configuration.

5. The compound of formula (III) of claim 4 , containing <3000 ppm methanol, under 0.1% (w/w) other solvents and under 0.2% (w/w) water.

6. A compound of claim 4 , wherein the compound is 1-(beta-D-ribofuranosyl)-1,4-dihydronicotinamide:

7. A compound according to claim 4 , wherein R 6 , R 7 and R 8 are each independently an ester-type protecting group selected from acetyl, propionyl, isopropionyl, benzoyl, and trihaloacetyl.

8. A compound according to claim 7 , wherein the ester-type protecting group is a protecting group selected from trifluoroacetyl and trichloroacetyl.

9. A compound according to claim 4 , wherein the R 6 , R 7 and R 8 moieties are selected from substituted and unsubstituted acetyl, and substituted and unsubstituted benzoyl.

10. A compound according to claim 4 , wherein at least two of R 6 , R 7 and R 8 are selected from unsubstituted acetyl or unsubstituted benzoyl.

11. A compound according to claim 10 , wherein the compound is triacetyl-1,4-dihydronicotinamide riboside:

12. A compound according to claim 10 , wherein the compound is tribenzoyl-1,4-dihydronicotinamide riboside:

13. A compound according to claim 4 , wherein the compound is 1-(beta-D-ribofuranosyl)-1,4-dihydronicotinic acid:

14. The compound of claim 1 , wherein n is 1; m is 0 or 1; and Y is S.

15. The compound of claim 1 , wherein

X − is an anion selected from an anion of a substituted or unsubstituted carboxylic acid, a halide, a substituted or unsubstituted phosphate, a substituted or unsubstituted sulfate, a substituted or unsubstituted carbonate, and a substituted or unsubstituted carbamate.

16. The compound of claim 1 , wherein n is 0 or 1; m is 0 or 1; Y is S; and

R 1 is selected from substituted or unsubstituted alkyl, substituted or unsubstituted alkenyl, substituted or unsubstituted alkynyl, and substituted or unsubstituted aryl.

17. The compound of claim 1 , wherein n is 0 or 1; m is 0 or 1; Y is S;

R 1 is selected from substituted or unsubstituted alkyl, substituted or unsubstituted alkenyl, substituted or unsubstituted alkynyl, and substituted or unsubstituted aryl and

X − is an anion selected from an anion of a substituted or unsubstituted carboxylic acid, a halide, a substituted or unsubstituted phosphate, a substituted or unsubstituted sulfate, a substituted or unsubstituted carbonate, and a substituted or unsubstituted carbamate.

18. The compound of claim 4 , wherein n is 0 or 1; m is 0 or 1; and Y is S.

19. The compound of claim 4 , wherein n is 1 and Y is S.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 17, 2026
From: QUEEN'S UNIVERSITY BELFAST
To: CHROMADEX INC.
Reel/Frame 075102/0433 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 11, 2020
From: MIGAUD, MARIE; REDPATH, PHILIP; CROSSEY, KERRI; DOHERTY, MARK
To: THE QUEEN'S UNIVERSITY OF BELFAST
Reel/Frame 052906/0548 →